The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases.

Lackie RE, Maciejewski A, Ostapchenko VG, Marques-Lopes J, Choy WY, Duennwald ML, Prado VF, Prado MAM. · 2017

Read The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases. by Lackie RE, Maciejewski A, Ostapchenko VG, Marques-Lopes J, Choy WY, Duennwald ML, Prado VF, Prado MAM. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5433227.txt.

Introduction

Lackie and co-authors review the protein-folding guards that falter in brain diseases. Their review appeared in Frontiers in Neuroscience. Many such diseases share one feature. Misfolded proteins pile up in the brain. In Alzheimer's disease, amyloid clumps and tau tangles are the marks. Chaperone proteins form a defense line. They refold bad proteins or send them for disposal. Two families, Hsp70 and Hsp90, anchor that system.

A helper called STI1 passes clients from Hsp70 to Hsp90. Cells can also release STI1 outside. There it acts like a growth signal. It can block amyloid from binding the prion protein. That binding is one route of amyloid harm. The review weighs mixed proof on Hsp90 drugs. Blocking Hsp90 helped Alzheimer's model mice. Yet lowering it harmed a worm amyloid model. The authors chart where the network helps or hurts. Tau, ALS, Parkinson's, and Huntington's diseases all get coverage.

Catalog record

CREATORLackie RE, Maciejewski A, Ostapchenko VG, Marques-Lopes J, Choy WY, Duennwald ML, Prado VF, Prado MAM.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE134 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5433227

Browse the full library · About the Tower of Babel